Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Zidovudine Plus Interleukin-2 and Ganciclovir in Treating Patients With AIDS-Related Primary Central Nervous System Lymphoma

This study has been completed.
National Cancer Institute (NCI)
Information provided by:
AIDS Malignancy Consortium Identifier:
First received: September 11, 2000
Last updated: February 1, 2016
Last verified: February 2016
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: July 2003
  Primary Completion Date: March 2003 (Final data collection date for primary outcome measure)